Related Experiment Video
Updated: Feb 18, 2026
09:33
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.7K
Validating cancer drug targets through chemical genetics
Mark E Burkard1, Prasad V Jallepalli
1University of Wisconsin Carbone Cancer Center and Department of Medicine, University of Wisconsin, Madison, WI 53792, USA. mburkard@wisc.edu
Biochimica Et Biophysica Acta
|August 17, 2010
Summary
Targeted cancer therapies aim to inhibit tumor growth. Chemical genetics offers a way to link cancer genome features to effective drug treatments, advancing rational cancer drug development.
Area of Science:
- Oncology
- Pharmacology
- Genetics
Background:
- Targeted cancer therapies, like imatinib for chronic myelogenous leukemia, show promise but face challenges due to tumor genetic diversity and complex drug interactions.
- Despite advances in sequencing, linking specific cancer genomic features to optimal therapies remains a significant hurdle.
Purpose of the Study:
- To explore chemical genetics as a method for rational cancer drug development.
- To address the challenge of matching targeted therapies to specific cancer genomic profiles.
Main Methods:
- Utilizing chemical genetics to establish a link between genetic makeup and drug response.
- Investigating methods for connecting specific cancer genome features to targeted therapies.
Main Results:
- Chemical genetics provides a framework for understanding drug susceptibility based on genetic alterations.
- This approach facilitates the rational design and selection of cancer therapies.
Conclusions:
- Chemical genetics is a vital tool for advancing targeted cancer therapy development.
- Overcoming tumor genetic complexity requires innovative approaches like chemical genetics to optimize treatment strategies.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
10
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
10
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
18
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
18
01:26Drug Discovery: Overview
12.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.0K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
01:26Targets for Drug Action: Overview
10.6K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.6K